Inventor · disambiguated record
Chengguo Dong
Also filed as: DONG CHENGGUO
24 granted patents·9 pending applications·158 citations·filing 2013–2025
96Inventor score
Files withVITAE PHARMACEUTICALS INC14VITAE PHARMACEUTICALS LLC13PLIANT THERAPEUTICS INC5KEZAR LIFE SCIENCES INC1
Top patents by PatentIndex Score
33 records- 0196US10793564B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·25 cites·69 claims
- 0295US11560376B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·6 cites·79 claims
- 0395US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0495US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0594US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0694US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0793US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0893US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 0993US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1092US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 1191US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 1291US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 1388US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 1487US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 1586US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 1686US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 1785US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 1884US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 1984US2025223288A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2080US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 2179US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 2278US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 2377US2023271960A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2475US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
- 2575US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2672US9388190B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·1 cites·16 claims
- 2765US2020138812A1Liver x receptor modulatorsVITAE PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2861US2020339566A1Dihydropyrrolopyridine inhibitors of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2960US2018117041A1Liver x receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3059US2025171434A1Sec61 inhibitors and use thereofKEZAR LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
- 3156US9814715B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·0 cites·16 claims
- 3255US2023181546A1Treatment of respiratory diseases with amino acid compoundsPLIANT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3336US10144715B2Piperazine derivatives as liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 4, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Chengguo Dong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →